AR020318A1 - Una molecula polinucleotidica aislada, un polipeptido aislado codificado por dicha molecula, un vector de expresion, una celula huesped transformada, unaproteina de fusion, una composicion farmaceutica y una vacuna que comprenden dicho polipeptido o proteina; metodos para el tratamiento, deteccion, - Google Patents
Una molecula polinucleotidica aislada, un polipeptido aislado codificado por dicha molecula, un vector de expresion, una celula huesped transformada, unaproteina de fusion, una composicion farmaceutica y una vacuna que comprenden dicho polipeptido o proteina; metodos para el tratamiento, deteccion,Info
- Publication number
- AR020318A1 AR020318A1 ARP990101169A ARP990101169A AR020318A1 AR 020318 A1 AR020318 A1 AR 020318A1 AR P990101169 A ARP990101169 A AR P990101169A AR P990101169 A ARP990101169 A AR P990101169A AR 020318 A1 AR020318 A1 AR 020318A1
- Authority
- AR
- Argentina
- Prior art keywords
- molecula
- isolated
- pharmaceutical composition
- expression vector
- fusion protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Una molécula polinucleotídica aislada, caracterizada porque comprende una secunecia de nucleotidos seleccionada del grupo consistente en: a) secuenciasprovistas en las SEQ.ID. NO: 1-3, 6-8, 10-13, 15-27, 29, 30, 32,34-49, 51, 52, 54, 55, 57-59, 61-69, 71, 73, 74, 77, 78, 80-82, 84, 86-96, 107-109, 111, 113,125, 127, 128, 129, 131-133, 142, 144, 148-151, 153, 154, 157, 158, 160, 167, 168 y 171; (b)los complementos de secuencias provistas en SEQ. ID, NO. 1-3, 6-8,10-13, 15-27, 29, 30, 32, 34-49, 51, 52, 54, 55, 57-59, 61-69, 71, 73,74,78,80-82, 84,86-96, 107-109, 111, 113, 125, 127, 128, 129, 131-133, 142, 144, 148-151,153, 154, 157, 158, 160, 167, 168 y 171; (c) secuencias que se hibridizan en una secuencia de (a) y (b) bajo condiciones moderadamente rigurosas. Unpolipéptido aislado, que comprende una porcion inmunogénica de una proteína de tumor pulmonar,ouna de sus variantes, comprende una secuencia de aminoácidos codificada por la molécula polinucleotídica. Un vector de expresion comprende la moléculapolinucleotídica; una célula huésped transformada con el vector de expresion; una proteína de fusion que comprende el polipéptido, una composicion farmacéuticay una vacuna que comprenden dicho polipéptido que comprende una porcion inmunogénica de una proteína de tumor pulmonar, o una de sus variantes y que comprendeuna secuencia de aminoácidos codificada por una molécula polinucleotídica que consiste en una secuencia seleccionada del grupo consistente en: (a)secuenciasprovistasen SEQ. ID. NO: 4, 5, 9, 14,28, 31, 33, 50, 53, 56, 60, 70, 72, 75, 76, 79, 83, 85, 97-106, 115-124, 126, 130, 134-141, 143, 145-147 y 162-164; (b)secuencias complementarias de las secuencias de SEQ. ID. NO:4, 5, 9, 14, 28, 31, 33, 50, 53, 56, 60, 70, 72, 75, 76, 79, 83, 85, 97-106, 115-124, 126, 130,134-141, 143, 145-147 y 162-164; (c)secunecias que se hibridizan en una secuencia de (a) y (b) bajo condiciones moderadamente rigurosas. Una composicionfarmacéutica y vacuna que comprenden la proteína de fusion. Métodos para el tratamiento, deteccion, monitoreo de la progresion e inhibicion del desarrollo de
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4080298A | 1998-03-18 | 1998-03-18 | |
US09/040,984 US6210883B1 (en) | 1998-03-18 | 1998-03-18 | Compounds and methods for diagnosis of lung cancer |
US12393398A | 1998-07-27 | 1998-07-27 | |
US09/123,912 US6312695B1 (en) | 1998-03-18 | 1998-07-27 | Compounds and methods for therapy of lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AR020318A1 true AR020318A1 (es) | 2002-05-08 |
Family
ID=45569967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990101169A AR020318A1 (es) | 1998-03-18 | 1999-03-17 | Una molecula polinucleotidica aislada, un polipeptido aislado codificado por dicha molecula, un vector de expresion, una celula huesped transformada, unaproteina de fusion, una composicion farmaceutica y una vacuna que comprenden dicho polipeptido o proteina; metodos para el tratamiento, deteccion, |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP2003201A3 (es) |
KR (1) | KR20010041992A (es) |
AR (1) | AR020318A1 (es) |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4489710A (en) | 1981-06-23 | 1984-12-25 | Xoma Corporation | Composition and method for transplantation therapy |
US4429008B1 (en) | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
JPS59116229A (ja) | 1982-12-24 | 1984-07-05 | Teijin Ltd | 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法 |
US4673562A (en) | 1983-08-19 | 1987-06-16 | The Children's Medical Center Corporation | Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents |
US4873088A (en) | 1983-09-06 | 1989-10-10 | Liposome Technology, Inc. | Liposome drug delivery method and composition |
US4625014A (en) | 1984-07-10 | 1986-11-25 | Dana-Farber Cancer Institute, Inc. | Cell-delivery agent |
US4542225A (en) | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
US4918164A (en) | 1987-09-10 | 1990-04-17 | Oncogen | Tumor immunotherapy using anti-idiotypic antibodies |
US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
US4699784A (en) | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
US4735792A (en) | 1987-04-28 | 1988-04-05 | The United States Of America As Represented By The United States Department Of Energy | Radioiodinated maleimides and use as agents for radiolabeling antibodies |
US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
WO1989001973A2 (en) | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Recombinant pox virus for immunization against tumor-associated antigens |
EP0398880A4 (en) | 1988-01-04 | 1990-12-27 | E.I. Du Pont De Nemours And Company | Multiple stage affinity process for isolation of specific cells from a cell mixture |
US5215926A (en) | 1988-06-03 | 1993-06-01 | Cellpro, Inc. | Procedure for designing efficient affinity cell separation processes |
AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
DE69032284T2 (de) | 1989-03-21 | 1998-10-08 | Vical, Inc., San Diego, Calif. | Expression von exogenen polynukleotidsequenzen in wirbeltieren |
WO1991002805A2 (en) | 1989-08-18 | 1991-03-07 | Viagene, Inc. | Recombinant retroviruses delivering vector constructs to target cells |
WO1991016116A1 (en) | 1990-04-23 | 1991-10-31 | Cellpro Incorporated | Immunoselection device and method |
DK0553288T3 (da) | 1990-10-18 | 1997-12-29 | Cellpro Inc | Apparat og fremgangsmåde til udskillelse af partikler ved brug af en eftergivende beholder |
WO1992020068A1 (en) | 1991-05-07 | 1992-11-12 | Sophos Technologic | Fast memory system employing mostly good memories |
US5240856A (en) | 1991-10-23 | 1993-08-31 | Cellpro Incorporated | Apparatus for cell separation |
US5359681A (en) | 1993-01-11 | 1994-10-25 | University Of Washington | Fiber optic sensor and methods and apparatus relating thereto |
US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
US5633161A (en) * | 1995-03-29 | 1997-05-27 | Millennium Pharmaceuticals, Inc. | Murine gene fomy030 coding for tumor progression inhibitor |
JPH11506332A (ja) | 1995-06-02 | 1999-06-08 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 全長cDNA配列を獲得する改良された方法 |
WO1999044620A1 (en) * | 1998-03-03 | 1999-09-10 | Magainin Pharmaceuticals, Inc. | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
-
1999
- 1999-03-17 AR ARP990101169A patent/AR020318A1/es unknown
- 1999-03-17 EP EP08165424A patent/EP2003201A3/en not_active Withdrawn
- 1999-03-17 EP EP06023711A patent/EP1792988A3/en not_active Withdrawn
- 1999-03-17 KR KR1020007010319A patent/KR20010041992A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2003201A2 (en) | 2008-12-17 |
KR20010041992A (ko) | 2001-05-25 |
EP1792988A2 (en) | 2007-06-06 |
EP1792988A3 (en) | 2007-08-22 |
EP2003201A3 (en) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gitt et al. | Evidence that a human soluble beta-galactoside-binding lectin is encoded by a family of genes. | |
WO2000003685A3 (en) | Nitrilase homologs | |
DK2014678T3 (da) | KDR-peptider og vacciner indeholdende disse | |
MX9708427A (es) | Serpina derivada de pancreas. | |
Lother et al. | Promoters in the E. coli replication origin | |
MY120693A (en) | Human bikunin | |
DK0550687T3 (da) | 5' til 3'-exonukleasemutationer af termostabile DNA-polymeraser | |
CA2901545A1 (en) | Use of spacer elements in a nucleic acid to control movement of a helicase | |
ES2054878T3 (es) | Expresion de la proapolipoproteina a-i humana. | |
DE69838334D1 (de) | Kdr, ein menschlicher tyrosin kinase rezeptor | |
BR9811592A (pt) | Oxidase de citocinina | |
WO1998006841A3 (en) | Two human nsp-like proteins | |
BR0004643A (pt) | Sequências de nucleotìdeos que codificam para o eno gene | |
AR010337A1 (es) | Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacuna | |
DK0811071T3 (da) | Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner | |
CO5280153A1 (es) | Antigeno asociados con tumores (r11) | |
ES2111536T3 (es) | Metodos y secuencias de acidos nucleicos para la expresion del operon de la sintasa de celulosa. | |
AR020318A1 (es) | Una molecula polinucleotidica aislada, un polipeptido aislado codificado por dicha molecula, un vector de expresion, una celula huesped transformada, unaproteina de fusion, una composicion farmaceutica y una vacuna que comprenden dicho polipeptido o proteina; metodos para el tratamiento, deteccion, | |
Edens et al. | Physical mapping of the central terminator for transcription on the bacteriophage M13 genome | |
ATE377087T1 (de) | Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors | |
Sanger et al. | Selected Papers of Frederick Sanger: With Commentaries | |
US9783800B2 (en) | Method for producing peptides having azole-derived skeleton | |
Lewis et al. | Homologous plasminogen N‐terminal and plasminogen‐related gene A and B peptides: Characterization of cDNAs and recombinant fusion proteins | |
MX9701596A (es) | Un homologo de quinasa de proteina activada por mitogeno humana. | |
ES2552598T3 (es) | Hemocianina y secuencia de ácido nucleico que codifica para la misma |